The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats

被引:15
作者
Tanabe, Jun [1 ]
Ogura, Yuji [2 ]
Nakabayashi, Mikie [3 ]
Nagai, Yoshio [4 ]
Watanabe, Shiika [1 ]
Sugaya, Takeshi [1 ]
Ohata, Keiichi [1 ]
Ichikawa, Daisuke [1 ]
Inoue, Kazuho [5 ]
Hoshino, Seiko [5 ]
Kimura, Kenjiro [6 ]
Shibagaki, Yugo [1 ]
Ono, Yumie [3 ]
Kamijo-Ikemori, Atsuko [1 ,5 ]
机构
[1] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Physiol, Kawasaki, Kanagawa, Japan
[3] Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kawasaki, Kanagawa, Japan
[4] St Marianna Univ, Sch Med, Dept Internal Med, Div Metab & Endocrinol, Kawasaki, Kanagawa, Japan
[5] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan
[6] JCHO Tokyo Takanawa Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
Diabetes; Diabetic kidney disease; Hypoxia; Kidney; Liver-type fatty acid-binding protein; Tubulointerstitial damage; TUBULOINTERSTITIAL INJURY; OXYGEN-CONSUMPTION; KIDNEY-DISEASE; RECEPTOR; HYPERGLYCEMIA; NEPHROPATHY; REFLECTS;
D O I
10.1159/000503926
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Renal hypoxia is an aggravating factor for tubulointerstitial damage, which is strongly associated with renal prognosis in diabetic kidney disease (DKD). Therefore, urinary markers that can detect renal hypoxia are useful for monitoring DKD. Objective: To determine the correlation between urinary liver-type fatty acid-binding protein (L-FABP) and renal hypoxia using a novel animal model of type 2 diabetes. Methods: Male spontaneously diabetic Torii (SDT) fatty rats (n = 6) were used as an animal model of type 2 diabetes. Age- and sex-matched Sprague-Dawley (SD) rats (n = 8) were used as controls. Body weight, systolic blood pressure, and blood glucose levels were measured at 8, 12, 16, and 24 weeks of age. Urine samples and serum and kidney tissues were collected at 24 weeks of age. Microvascular blood flow index (BFI) was measured using diffuse correlation spectroscopy before sampling both the serum and kidneys for the evaluation of renal microcirculation at the corticomedullary junction. Results: Obesity, hyperglycemia, and hypertension were observed in the SDT fatty rats. Focal glomerular sclerosis, moderate interstitial inflammation, and fibrosis were significantly more frequent in SDT fatty rats than in SD rats. While the frequency of peritubular endothelial cells and phosphoendothelial nitric oxide synthase levels were similar in both types of rats, the degree of renal hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression was significantly higher (and with no change in renal vascular endothelial growth factor expression levels) in the SDT fatty rats. Urinary L-FABP levels were significantly higher and renal microvascular BFI was significantly lower in the SDT fatty rats than in the SD rats. Urinary L-FABP levels exhibited a significant positive correlation with renal HIF-1 alpha expression and a significant negative correlation with renal microvascular BFI. Conclusions: Urinary L-FABP levels reflect the degree of renal hypoxia in DKD in a type 2 diabetic animal model. Urinary L-FABP may thus prove useful as a renal hypoxia marker for monitoring DKD in patients with type 2 diabetes in clinical practice.
引用
收藏
页码:1476 / 1492
页数:17
相关论文
共 50 条
  • [21] Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
    T. Nakamura
    T. Sugaya
    H. Koide
    Diabetologia, 2007, 50 : 490 - 492
  • [22] Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
    Nakamura, T.
    Sugaya, T.
    Koide, H.
    DIABETOLOGIA, 2007, 50 (02) : 490 - 492
  • [23] Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD
    Matsui, Katsuomi
    Kamijo-Ikemori, Atsuko
    Imai, Naohiko
    Sugaya, Takeshi
    Yasuda, Takashi
    Tatsunami, Shinobu
    Toyama, Tadashi
    Shimizu, Miho
    Furuichi, Kengo
    Wada, Takashi
    Shibagaki, Yugo
    Kimura, Kenjiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (02) : 195 - 203
  • [24] Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy
    Nakamura, Tsukasa
    Fujiwara, Nobuharu
    Sugaya, Takeshi
    Ueda, Yoshihiko
    Koide, Hikaru
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (08): : 1185 - 1190
  • [25] Renal Liver-Type Fatty Acid Binding Protein Attenuates Angiotensin II-Induced Renal Injury
    Ichikawa, Daisuke
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Yasuda, Takashi
    Hoshino, Seiko
    Igarashi-Migitaka, Jyunko
    Hirata, Kazuaki
    Kimura, Kenjiro
    HYPERTENSION, 2012, 60 (04) : 973 - +
  • [26] Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals
    Kosaki, Keisei
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Tanahashi, Koichiro
    Kumagai, Hiroshi
    Sawano, Yuriko
    Akazawa, Nobuhiko
    Ra, Song-Gyu
    Kimura, Kenjiro
    Shibagaki, Yugo
    Maeda, Seiji
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 810 - 817
  • [27] Effect of habitual exercise on urinary liver-type fatty acid-binding protein levels in middle-aged and older adults
    Kosaki, K.
    Kamijo-Ikemori, A.
    Sugaya, T.
    Tanahashi, K.
    Sawano, Y.
    Akazawa, N.
    Ra, S. -G.
    Kimura, K.
    Shibagaki, Y.
    Maeda, S.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2018, 28 (01) : 152 - 160
  • [28] Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure
    Okubo, Yousaku
    Sairaku, Akinori
    Morishima, Nobuyuki
    Ogi, Hiroshi
    Matsumoto, Takeshi
    Kinoshita, Hiroki
    Kihara, Yasuki
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : 520 - 524
  • [29] Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care
    Doi, Kent
    Noiri, Eisei
    Sugaya, Takeshi
    CURRENT OPINION IN CRITICAL CARE, 2010, 16 (06) : 545 - 549
  • [30] URINARY LIVER-TYPE FATTY ACID-BINDING PROTEIN IN SEPTIC SHOCK: EFFECT OF POLYMYXIN B-IMMOBILIZED FIBER HEMOPERFUSION
    Nakamura, Tsukasa
    Sugaya, Takeshi
    Koide, Hikaru
    SHOCK, 2009, 31 (05): : 454 - 459